LAKE
FOREST, Calif., June 14,
2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL),
the global leader in dental lasers, today announced an arrangement
with Pet Dental Services (PDS), the #1 non-anesthetic pet dental
provider in the country, to integrate BIOLASE's diode laser
technology. PDS' vision in the animal health care profession is to
gain the trust and confidence of veterinarians throughout the
country and to provide service through veterinary hospitals coast
to coast. PDS has been providing anesthesia-free dental care for
over 10 years and has established an excellent reputation
among a network of more than 300 veterinarians.
Through adopting BIOLASE's diode laser technology, PDS will now
provide veterinarians with one of the most cutting-edge care
available for their pet patients. According to the American
Veterinary Dental Society, 80% of dogs and 70% of cats show signs
of periodontal disease by the age of 3. In these cases, bacteria
infects gum tissue and the roots of teeth resulting in disease and
tooth loss. In addition to the negative impact on oral health,
bacteria can also enter the bloodstream through the large blood
vessels located near pets' gums and teeth. Organs with the highest
blood flow are most susceptible to infections, including the lungs,
heart, kidneys, liver and even the brain. Damage to these organs
caused by infection can drastically shorten pets' lives.
"Our industry-leading diode laser technology is designed to be a
great fit for a non-traditional dental care provider like Pet
Dental Services," said John Beaver,
President and Chief Executive Officer of BIOLASE. "With a focus on
offering veterinarians and pet owners experience and expertise that
is second to none, we believe Pet Dental Services promises the very
best in anesthesia-free dental care for dogs and cats. The adoption
of our innovative technology can help fulfill that promise. Not
only does our technology treat periodontal disease, it can also
help pets live healthier lives."
PDS' representative said of the partnership, "The integration of
the latest dental technology is key to providing superb
non-anesthetic patient care. Working with pets in this
environment can be a challenge, but with the right techniques and
tools–like BIOLASE's diode technology–pets too can enjoy the
exponential benefits of excellent dental care. We strive to provide
pet owners the most innovative care for their beloved
pets. BIOLASE will help us to do just that."
About Pet Dental Services
Pet Dental Services (PDS) has over 10 years of experience
providing dental cleanings for dogs and cats without the use of
anesthesia, partnering with over 300 licensed veterinarians
nationwide. Our trademarked 11-step Professional Outpatient
Preventive Dental (POPD) has been proven safe and effective through
a double-blind study performed with a board-certified veterinary
dentist. PDS is the #1 provider in the country offering over 15,000
cleanings per year. We take pride in our professionalism and most
importantly our gentle, compassionate approach utilizing Fear Free
and Cat Friendly handling techniques.
For updates and information on Pet Dental Services, find PDS
online at www.petdentalservices.com, Facebook at
www.facebook.com/petdentalservices.com Instagram at
www.instagram.com/petdentalservices.com
About BIOLASE
BIOLASE is a medical device company that develops, manufactures,
markets, and sells laser systems in dentistry and medicine.
BIOLASE's products advance the practice of dentistry and medicine
for patients and healthcare professionals. BIOLASE's proprietary
laser products incorporate approximately 266 patented and 25
patent-pending technologies designed to provide biologically and
clinically superior performance with less pain and faster recovery
times. BIOLASE's innovative products provide cutting-edge
technology at competitive prices to deliver superior results for
dentists and patients. BIOLASE's principal products are dental
laser systems that perform a broad range of dental procedures,
including cosmetic and complex surgical applications. From 1998
through December 31, 2022, BIOLASE
has sold over 45,500 laser systems in over 80 countries around the
world. Laser products under development address BIOLASE's core
dental market and other adjacent medical and consumer
applications.
For updates and information on Waterlase iPlus®, Waterlase
Express™, and laser dentistry, find BIOLASE online at
www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at
www.twitter.com/biolaseinc, Instagram at
www.instagram.com/waterlase_laserdentistry, and LinkedIn at
www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered
trademarks of BIOLASE, Inc.
Cautionary Statement Regarding Forward-Looking
Statements
This press release contains forward-looking
statements, as that term is defined in the Private Securities
Litigation Reform Act of 1995, that involve significant risks and
uncertainties, including statements regarding PDS' plans to
integrate BIOLASE's diode laser technology, BIOLASE's laser
technology being a great fit for a non-traditional dental care
provider like Pet Dental Services, Pet Dental Services promising
the very best in anesthesia-free dental care for dogs and cats and
the adoption of BIOLASE's technology helping Pet Dental Services
fulfill its promise to provide the very best in anesthesia-free
dental care for dogs and cats and BIOLASE's technology helping
pets live healthier lives. Forward-looking statements can be
identified through the use of words such as "may," "might," "will,"
"intend," "should," "could," "can," "would," "continue," "expect,"
"believe," "anticipate," "estimate," "predict," "outlook,"
"potential," "plan," "seek," and similar expressions and variations
or the negatives of these terms or other comparable terminology.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which reflect BIOLASE's current
expectations and speak only as of the date of this release. Actual
results may differ materially from BIOLASE's current expectations
depending upon a number of factors. These factors include, among
others, BIOLASE's ability to realize the benefits expected from the
arrangement with PDS, the ability of BIOLASE's technology to help
Pet Dental Services fulfill its promise to provide the very best in
anesthesia-free dental care for dogs and cats, adverse changes
in general economic and market conditions, competitive factors
including, but not limited to, pricing pressures and new product
introductions, uncertainty of customer acceptance of new product
offerings and market changes, risks associated with managing the
growth of the business, substantial doubt regarding BIOLASE's
ability to continue as a going concern, risks associated with the
inability to raise additional capital on acceptable terms and those
other risks and uncertainties that are described in the "Risk
Factors" section of BIOLASE's most annual report on Form 10-K for
the year ended December 31, 2022,
quarterly reports on Form 10-Q, current reports on Form 8-K and
subsequent filings the Securities and Exchange Commission. The
information in this release is provided only as of the date of this
release, and BIOLASE undertakes no obligation to update or revise
publicly any forward-looking statements, whether as a result of new
information, future events or otherwise, after the date on which
the statements are made or to reflect the occurrence of
unanticipated events, except as required by law.
For further information, please contact:
EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolase-integrates-diode-laser-technology-with-pet-dental-services-301850335.html
SOURCE BIOLASE, Inc.